Men who have sex with men, risk behavior, and HIV infection: Integrative analysis of clinical, epidemiological, and laboratory databases

Clinical Infectious Diseases

Volumn 52, Issue 11, 2011, Pages 1363-1370

  Levy, Itzchak ^a   Mor, Zohar ^b   Anis, Emilia ^b   Maayan, Shlomo ^c   Leshem, Eyal ^a   Pollack, Shimon ^d   Chowers, Michal ^e   Mor, Orna ^a   Riesenberg, Klaris ^f   Sthoeger, Zev ^g   Ram, Daniela ^a   Grossman, Zehava ^a,h  

^a SHEBA MEDICAL CENTER   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d RAMBAM MEDICAL CENTER   (Israel)

^e MEIR MEDICAL CENTER   (Israel)

^f BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^g KAPLAN MEDICAL CENTER   (Israel)

^h TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; DATA BASE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISRAEL; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MIXED INFECTION; PHYLOGENY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYPHILIS; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; GENOTYPE; HIV; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; ISRAEL; MALE; MOLECULAR EPIDEMIOLOGY; MUTATION, MISSENSE; PHYLOGENY; RETROSPECTIVE STUDIES; RISK-TAKING; YOUNG ADULT;

EID: 79957502497     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir244     Document Type: Article

References (27)

1. Mor Z, Davidovich U, McFarlane M, Feldshtein G, Chemtob D. Gay men who engage in substance use and sexual risk behaviour: A dual-risk group with unique characteristics. Int J STD AIDS 2008; 19: 698-703.
2. Chemtob D, Mor Z. HIV/AIDS in Israel, epidemiological periodic report 1981-2008. Israel: Public Health Services, Department of Tuberculosis & AIDS, MOH, 2009.
3. Chemtob D, Grossman Z. Epidemiology of adult and adolescent HIV infection in Israel: A country of immigration. Int J STD AIDS 2004; 15:691-6. (Pubitemid 39331296)
4. Grossman Z, Lorber M, Maayan S, et al. Drug-resistant HIV infection among drug-naive patients in Israel. Clin Infect Dis 2005; 40:294-302. (Pubitemid 40110677)
5. The Commission on AIDS in Asia. Redefining AIDS in Asia. Crafting an effective response. New Delhi: The Commission on AIDS in Asia, 2008.
6. Bengtsson L, Thorson A. Global HIV surveillance among MSM: Is risk behavior seriously underestimated? AIDS 2010; 24:2301-3.
7. Jaffe HW, Valdiserri RO, De Cock KM. The reemerging HIV/AIDS epidemic in men who have sex with men. JAMA 2007; 298: 2412-4. (Pubitemid 350190783)
8. Likatavicius G, Klavs I, Devaux I, Alix J, Nardone A. An increase in newly diagnosed HIV cases reported among men who have sex with men in Europe, 2000-6: Implications for a European public health strategy. Sex Transm Infect 2008; 84:499-505.
9. van de Laar MJ, Likatavicius G. HIV and AIDS in the European Union, 2008. Euro Surveill 2009; 14:5-7.
10. Baral S, Trapence G, Motimedi F, et al. HIV prevalence, risks for HIV infection, and human rights among men who have sex with men (MSM) in Malawi, Namibia, and Botswana. PLoS One 2009; 4:e4997.
11. Crepaz N, Marks G, Liau A, et al. Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States: A metaanalysis. AIDS 2009; 23:1617-29.
12. Baral S, Sifakis F, Cleghorn F, Beyrer C. Elevated risk for HIV infection among men who have sex with men in low-and middle-income countries 2000-2006: A systematic review. PLoS Med 2007; 4:e339.
13. Brenner BG, Roger M, Routy JP, et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007; 195:951-9. (Pubitemid 46452099)
14. Schupbach J, Gebhardt MD, Tomasik Z, et al. Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation. PLoS Med 2007; 4:e343.
15. Wensing AM, van de Vijver DA, Angarano G, et al. Prevalence of drugresistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management. J Infect Dis 2005; 192:958-66. (Pubitemid 41266791)
16. Vercauteren J, Wensing AM, van de Vijver DA, et al. Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Infect Dis 2009; 200:1503-8.
17. Paraskevis D, Pybus O, Magiorkinis G, et al. Tracing the HIV-1 subtype B mobility in Europe: A phylogeographic approach. Retrovirology 2009; 6:49.
18. Bennett DE, Camacho RJ, Otelea D, et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One 2009; 4:e4724.
19. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24:1596-9. (Pubitemid 47236692)
20. Semaille C, Cazein F, Lot F, et al. Recently acquired HIV infection in men who have sex with men (MSM) in France, 2003-2008. Euro Surveill 2009; 14:1-4.
21. Savage EJ, Hughes G, Ison C, Lowndes CM. Syphilis and gonorrhoea in men who have sex with men: A European overview. Euro Surveill 2009; 14:40-7.
22. Greenblatt RM, Lukehart SA, Plummer FA, et al. Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS 1988; 2:47-50. (Pubitemid 18085319)
23. Palacios R, Jimenez-Onate F, Aguilar M, et al. Impact of syphilis infection on HIV viral load and CD4 cell counts in HIV-infected patients. J Acquir Immune Defic Syndr 2007; 44:356-9. (Pubitemid 46328355)
24. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med 1997; 337:307-14. (Pubitemid 27318992)
25. Ostrow DE, Fox KJ, Chmiel JS, et al. Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIVinfected and uninfected homosexual men. AIDS 2002; 16:775-80. (Pubitemid 34274468)
26. Diallo K, Gotte M, Wainberg MA. Molecular impact of the M184V mutation in human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 2003; 47:3377-83. (Pubitemid 37345693)
27. Brenner BG, Roger M, Moisi DD, et al. Transmission networks of drug resistance acquired in primary/early stage HIV infection. AIDS 2008; 22:2509-15.